Adiposity-independent hypoadiponectinemia as a potential marker of insulin resistance and inflammation in schizophrenia patients treated with second generation antipsychotics
详细信息    查看全文
文摘
The purpose of this study was to explore body fat independent effect of second generation antipsychotics (SGAs) on measures of glucose and adipokine homeostasis, and markers of inflammation.

Method

Eight non-diabetic men with schizophrenia (age: 55 ± 3 years, BMI: 29.7 ± 1.2 kg/m2) on SGAs were studied after an overnight fast. DXA and single-cut CT of abdomen were respectively used for the assessment of total body and abdominal fat. Blood samples were collected for measurements of glucose, insulin, leptin, adiponectin, C-reactive protein (CRP), and TNF-α. Data in schizophrenic subjects were compared to eight age (55 ± 2.8 years) and BMI (29.6 ± 1.1 kg/m2) matched healthy men.

Results

The results were significant for markedly decreased serum adiponectin in schizophrenia patients (4.6 ± 0.9 vs 11.1 ± 1.5 ng/mL, p = 0.001). Lower levels of adiponectin in schizophrenia men were associated with significant increases in insulin resistance (4.2 ± 0.7 vs 1.7 ± 0.4, p = 0.004), CRP (3.5 ± 1.2 vs 1.2 ± 0.3, p = 0.037), and leptin (12 ± 1.4 vs 8.5 ± 1.4 ng/mL, p = 0.05). Various measures of adiposity, including fat mass index (FMI) and abdominal fat were not different in the two study groups.

Conclusions

These findings in the context of comparable age and total body/abdominal fat mass are assumed to be either disease specific, and/or treatment inflicted. The definitive invoking etiology and a presumptive role of hypoadiponectinemia in the development of insulin resistance and increased risk of inflammation warrant future investigation.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700